Cell Therapeutics Inc. (CTIC) Posts Surprise Q4 Profit of 8c/Share
Cell Therapeutics Inc. (NASDAQ: CTIC) reported Q4 EPS of $0.08 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)